Читать книгу Biologics, Biosimilars, and Biobetters - Группа авторов - Страница 13

 Many different terms are used for innovator biologics, biosimilars, and biobetters internationally.

 Greater harmonization of terminology, definitions, and nomenclature across different regulatory jurisdictions and countries would assist health practitioners and patients in understanding the complex issues of biologic medicines.

 The salient language of innovator biologics, biosimilars, and biobetters are introduced in this chapter to set the context for the rest of the book, which deals with specific issues in greater detail pitched at pharmacists, doctors, and patients.